SCIENCE
Imperial spinout MintNeuro raises $5 million for neural-device chips
A 7 October Imperial report says MintNeuro has raised $5 million to develop its chip platform for neural devices. The currency is dollars, and the announcement concerns technology development—not a newly approved treatment.

The work behind the funding
The university describes MintNeuro as an Imperial spinout founded in 2022.
The funding supports scaling its chip platform and work with partners developing neural technologies. Chips are one component in a much larger medical-device pathway.
- Article type
- Research news
- Sources checked
- 21 October 2026; not live booking inventory
On this page
Do not jump from funding to a cure
Investment does not establish clinical effectiveness, regulatory approval or availability to patients.
A promising engineering platform still requires evidence in the setting in which it will be used. The announcement does not remove those distinctions.
Read the next milestone carefully
Useful follow-up would identify what has been tested, by whom and with what outcome.
This report is not medical or investment advice and does not recommend a device, treatment or company to an individual.
LONNOW.COM

